7-4783682-A-G
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_014855.3(AP5Z1):c.512-7A>G variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0202 in 1,548,868 control chromosomes in the GnomAD database, including 2,858 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★).
Frequency
Consequence
NM_014855.3 splice_region, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
AP5Z1 | NM_014855.3 | c.512-7A>G | splice_region_variant, intron_variant | ENST00000649063.2 | NP_055670.1 | |||
AP5Z1 | NM_001364858.1 | c.44-7A>G | splice_region_variant, intron_variant | NP_001351787.1 | ||||
AP5Z1 | XM_047421098.1 | c.176-7A>G | splice_region_variant, intron_variant | XP_047277054.1 | ||||
AP5Z1 | NR_157345.1 | n.605-7A>G | splice_region_variant, intron_variant |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0797 AC: 12123AN: 152098Hom.: 1475 Cov.: 33
GnomAD3 exomes AF: 0.0191 AC: 2945AN: 154268Hom.: 267 AF XY: 0.0156 AC XY: 1275AN XY: 81990
GnomAD4 exome AF: 0.0137 AC: 19151AN: 1396654Hom.: 1377 Cov.: 32 AF XY: 0.0125 AC XY: 8631AN XY: 688626
GnomAD4 genome AF: 0.0798 AC: 12148AN: 152214Hom.: 1481 Cov.: 33 AF XY: 0.0760 AC XY: 5655AN XY: 74424
ClinVar
Submissions by phenotype
Hereditary spastic paraplegia 48 Benign:2
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 13, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Athena Diagnostics | Dec 05, 2023 | - - |
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jan 30, 2019 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at